An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…

Sanofi

Chutes & Ladders: Genentech oncology head jumps ship

Enteris BioPharma signs oral diabetes pact with Sanofi

Evotec now not only a partner to Eternygen but also an investor

Regeneron, Sanofi’s hotly tipped atopic dermatitis drug dupilumab accepted for review at EMA

Sanofi takes over Warp Drive antibiotic program

Sanofi, Novartis, NCI, Ranbaxy top missing data list as Shire most transparent

Sanofi/Regeneron hit with FDA delay for sarilumab

Lexicon gains on positive PhII data in Type 1 diabetes

Sanofi helps Science 37 raise $31M to ‘reimagine’ clinical trials